Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04494139
Other study ID # IREC173/18
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 1, 2020
Est. completion date June 1, 2023

Study information

Verified date July 2020
Source Durban University of Technology
Contact Ashika Naicker, PhD
Phone 3732333
Email ashikan@dut.ac.za
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

As an important way to translate cardiovascular disease prevention efforts, worksite interventions can facilitate healthy food choices, health education, and social support. This proposed project is adapted and scaled-up from the Nepal study, and will measure the effectiveness of a canteen and a behavioral intervention on cardio-metabolic risk at a worksite in South Africa. This study will estimate the added benefit of a proven individual-level dietary intervention over environmental-level changes for preventing cardio-metabolic risk within the South African context. If the study demonstrates a significant effect, a scaled-up approach could produce an important reduction in cardiovascular disease burden through environmental and individual level prevention programs in South Africa.


Description:

The effectiveness of the multi-component environmental worksite intervention will be measured by evaluating the change in number of individuals attaining two or more cardiometabolic risk reduction goals (i.e., reductions in HbA1c, blood pressure, triglycerides, cholesterol and weight). Secondary outcomes will include the individual changes in the risk factors included in the primary outcome, as well as in cardiometabolic risk not included in the composite score (i.e., LDL, HDL, total cholesterol/HLD ratio), in dietary intake, in physical activity, and in worksite-level food and beverage sales.

Specific objectives is as follows:

1. To measure the effectiveness of a canteen intervention on a composite score based upon improvement in cardio-metabolic risk factors (0-3) with success defined by HbA1c decrease ≥0.5%; a systolic blood pressure decrease ≥5 mmHg; and a decrease in plasma triglycerides ≥10 mg/dl. We will compare the change in the score after six months of the canteen intervention to the baseline results.

2. To measure the effectiveness of a behavioral intervention on a composite score based upon improvement in cardio-metabolic risk factors (0-3) with success defined by HbA1c decrease ≥0.5%; a systolic blood pressure decrease ≥5 mm Hg. We will compare the change in the score in behavior intervention group to the baseline results.

3. To measure the effectiveness of a canteen intervention on diabetes risk (By comparing the change in HbA1c of participants after six months of canteen intervention to the baseline results).

4. To measure the effectiveness of a behavioral intervention on diabetes risk (By comparing the change in HbA1c of participants after six months of behavior plus canteen intervention to the change over six months during the canteen only intervention).

5. To measure the combined effect of canteen and behavioral intervention on diabetes risk (By comparing the change in HbA1c levels of the participants of canteen plus behavioral intervention to baseline results).

6. To measure the effectiveness of a canteen intervention on dietary behavior (By comparing change in the proportion of healthy foods adopted by the participants after six months of canteen intervention to the change in the proportion of healthy food consumption at baseline).

7. To measure the effectiveness of a behavioral intervention on dietary behavior (By comparing the change in the proportion of healthy foods eaten by the participants after six months of behavior plus canteen intervention to the change over six months during the canteen only intervention) Interventions The study will recruit 350 employees at a worksite in Durban, Kwa Zulu Natal using the worksite characteristic checklist for best fit to the study. Formative work will be done to determine the best fit for the implementation of the intervention to the worksite. At baseline, 6 months, 12 months and 18 months, standard questionnaire will be administered to record relevant characteristics of the participants, physical activity, smoking, stress, alcohol intake and diet. Food sales data will be abstracted from the administrative database of the canteen. Blood samples will be collected and analyzed for HbA1c, fasting glucose, and lipid profile (HDL, LDL, total cholesterol, triglycerides). Participants height, weight, waist circumference, hip circumference, and blood pressure will be measured. After 6 months of control period, the participants will receive the canteen intervention. After six months of the canteen/physical environment intervention, half of the participants will be randomized to receive a canteen and behavioral intervention; whereas the other half receives canteen only intervention. The behavioral intervention will be comprised of a combination of intensive education sessions and goal setting and monitoring based on a validated worksite curriculum tailored to local needs. The curriculum will include 24 sessions: 16 core weekly sessions during the first four months of the intervention followed by 8 weekly maintenance sessions (text messages). Each session will be facilitated by a nutritionist/dietitian and a peer educator; and will last one hour. Broadly, the curriculum will cover the subject matters of importance of healthy weight, eating a healthy diet, increasing physical activity, stress management, and challenges of lifestyle changes. Participants will be encouraged to keep food and activity diaries throughout the course of the study. During the maintenance period, the focus will be on overcoming declines in motivation and on maintaining long-term healthy behaviors. Participants will set at least two lifestyle change goals such as consuming half of the total grains as whole grains, walking 30 minutes a day, reducing 7% of the body weight, and similar goals to achieve during the sessions based on their baseline CVD profile. Participants will be followed up at 6 months (at the end of step 1 intervention), 12 months (at the end of step 2 intervention). During each follow up, fasting blood samples will be collected and analyzed for HbA1c, fasting glucose, and lipid profile (HDL, LDL, total cholesterol, triglycerides).

The primary analysis will use chi squared test use to compare (a) Proportion of individual with score ≥ 2 during canteen only intervention to the proportion of individual with score ≥ 2 during the control period; (b) Proportion of individual with score ≥ 2 during canteen and behavioral intervention to the proportion of individual with score ≥ 2 during canteen only intervention. Logistic regression for the proportion of individual with score ≥ 2 as outcome and canteen only vs canteen and behavioural as exposure will be conducted. Secondary analysis will use paired t-test to compare (a) the change in healthy food intake and HbA1c during canteen only intervention to the change in healthy food intake and HbA1C during the control period (b) the change in healthy food intake and HbA1C% during canteen and behavioral intervention to the change in healthy food intake and HbA1C% during canteen only intervention.

The following process outcomes will be measured:

1. Program adoption will be measured by quantifying workers participation through calculating the percentages of total employees agreeing to screening, and percentages agreeing to participate in the intervention.

2. Program fidelity will be determined by measuring changes in the worksite environment, and management support for the program. To assess compliance to the recommended dietary interventions (i.e., provide healthy food options in the canteen, eliminate SSBs) every month in the intervention period, a member of the study team not affiliated with the worksite will do a random audit.

3. Program feasibility will be measured by quantifying the changes in sales of healthy and unhealthy foods and beverages at the canteen from baseline to follow-up.

4. Program adoption and acceptability will be assessed through focus group discussions with employees (lifestyle participants and lifestyle drop outs) managers and non-eligible participants on worksite environmental changes.

5. The value and return on investment of the intervention for employers will be measured by assessing program cost and cost-effectiveness and changes in staff productivity, absenteeism, health status, and quality of life.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 350
Est. completion date June 1, 2023
Est. primary completion date December 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Full time employees

- 18 years or above of age

- No confirmation of diabetes and, not on diabetes medication OR Have HbA1c of 5.7% to 6.4%. OR Prediabetes group with FBS of 100- 126 mg/dL Systolic blood pressure 120 mm Hg or more or Diastolic blood pressure 80 mm Hg or more and not on blood pressure medication

Exclusion Criteria:

- Less than 18 years

- On diabetes medication

- On hypertension medication

Study Design


Intervention

Behavioral:
Behavioral and Canteen intervention
Behavioral intervention: 16 weeks
Other:
Canteen
Canteen changes to introduce health foods

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Durban University of Technology Dhulikhel Hospital, Yale University

Outcome

Type Measure Description Time frame Safety issue
Primary Cardiometabolic Risks A composite score based upon improvement in 3 cardio-metabolic risk factors (0-3) [HbA1c decrease =0.5%; a systolic blood pressure decrease (SBP) =5 mm Hg; and plasma triglycerides decrease =10 mg/d six months
Primary Healthy food intake Intake of whole grains, fruits and vegetables and other healthy labelled items in the canteen from sales data Six months
Secondary Hba1c Glycated haemoglobin, % continuous variable Six months
Secondary Systolic Blood pressure An average of three measurements, mmHg continuous variabl Six months
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A